Outcomes of Patients with Critical Limb Ischaemia in the EUCLID Trial

Author:

Norgren Lars,Patel Manesh R.,Hiatt William R.,Wojdyla Daniel M.,Fowkes F. Gerry R.,Baumgartner Iris,Mahaffey Kenneth W.,Berger Jeffrey S.,Jones W. Schuyler,Katona Brian G.,Held Peter,Blomster Juuso I.,Rockhold Frank W.,Björck MartinORCID

Funder

AstraZeneca

Bayer

AnGes MG

Pluristem Therapeutics

Cesca Therapeutics

Mitsubishi Tanabe Pharma

CSI

Genzyme

Janssen Research & Development

Medtronic

Merck

HeartFlow

Maquet

NHLBI

Jansen

Pluristem

Sanofi

Abbott Vascular

Cook Medical

Optimed

Terumo Medical

Promedics

Amgen

Boston Scientific

BAROnova

Bio2 Medical

Boehringer Ingelheim

Bristol-Myers Squibb

Cubist

Eli Lilly

Epson

Forest Laboratories

GlaxoSmithKline

Johnson & Johnson

MyoKardia

Omthera Pharmaceuticals

Portola Pharmaceuticals

Purdue Pharma

Medicines Company

Theravance

Vindico

WebMD

Daiichi-Sankyo

St. Jude Medical

Tenax Therapeutics

Janssen

Takeda

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Surgery

Cited by 30 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3